Opinion ID: 331435
Heading Depth: 1
Heading Rank: 2

Heading: Abbott Laboratories and Dr. Javurek.

Text: 18 Plaintiff contends the warning or package insert (quoted above) which accompanied Penthrane was inadequate to warn of the dangers incident to the use of the drug. 19 Plaintiff produced no evidence to establish the insufficiency of this warning. Both of the expert witnesses agreed that the warning on the drug insert was proper and adequate. Indeed, Dr. William K. Hamilton, whose testimony was introduced by the plaintiff, testified that a stronger warning would have been incorrect. Plaintiff offered no evidence to the contrary. Accordingly, based on the testimony in this case, the dismissal of Abbott Laboratories must be sustained. 5 20 As we have noted, Dr. Javurek assisted in the surgery. No evidence indicated that he exercised any control over Dr. Trinidad or participated in the selection of the anesthesia to be administered to Mrs. Carlsen. While nurse-anesthetist Johnson testified that prior to surgery she advised Dr. Javurek of her intention to use Penthrane in the surgery and that he shrugged his shoulders in response, a gesture which she considered to be a signal of partial approval and partial disapproval, this testimony does not show any participation by Dr. Javurek in the selection of an anesthesia and we can find no evidence of negligent conduct by him in this record. Under these circumstances, plaintiff did not make a case against Dr. Javurek. Any trial errors, as discussed below, do not affect the claim against Dr. Javurek and the dismissal of the action against him must be sustained. 21